Medtronic

Public

Surgical & medical robot

Exchange: MDT · NYSE
Region: US

Maker of the Hugo robotic-assisted surgery system; received FDA clearance for urologic procedures in December 2025, becoming the first major medtech company to challenge Intuitive Surgical's da Vinci in soft-tissue robotic surgery in the US.

Stock & market data

TradingView →

Price and market-cap figures come from an embedded TradingView widget — we don't store or curate that data ourselves, and it may be delayed rather than real-time depending on the exchange.

Investor note

Hugo is already used in 30+ countries for tens of thousands of procedures, but its US commercial ramp is just beginning; Medtronic is also seeking clearance for general surgery and gynecology. Robotics is one growth bet within a much larger diversified medtech portfolio.

Last checked: 2026-07-07